Observational study / 2009
Grapefruit intake was not associated with breast cancer risk in a large prospective cohort of European women.
In the EPIC study, 114,504 women were followed for a median of 9.5 years, during which 3,747 incident breast cancers were identified. Fifty-nine percent reported eating grapefruit, and 4% consumed 60 g/day or more. Grapefruit intake was not related to breast cancer risk: compared to non-consumers, those with the highest intake (>=60 g/day) had a hazard ratio of 0.93 (95% CI 0.77-1.13; p for linear trend = 0.5). Subgroup analyses by menopausal status and hormone replacement therapy use also showed no relationship, nor was there an association with estradiol or estrone among postmenopausal women.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 114,504 women in EPIC followed for a median of 9.5 years
- What was measured
- Risk of breast cancer and serum sex hormone levels
THE PAPER
Prospective study of the association between grapefruit intake and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Spencer EA, Key TJ, Appleby PN, van Gils CH, Olsen A, Tjønneland A, Clavel-Chapelon F, Boutron-Ruault MC, Touillaud M, Sánchez MJ, Bingham S, Khaw KT, Slimani N, Kaaks R, Riboli E. Cancer Causes Control, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.